Model-based or algorithm-based? Statistical evidence for diabetes and treatments using gene expression.
Gene expression profiles obtained from samples of diabetic and normal rats with and without treatments can be used to identify genes that distinguish normal and diabetic individuals and also to evaluate the effectiveness of drug treatments. This study examines changes in global gene expression in rat muscle caused by streptozotocin-induced diabetes and vanadyl sulfate treatment. We explored model-based and algorithm-based methods with gene screening measures for microarray gene expression data to classify and predict individuals with high risk of diabetes. Results show that the mixed ANOVA model-based approach provides an efficient way to conduct an investigation of the inherent variability in gene expression data and to estimate the effects of experimental factors such as treatments and diseases and their interactions. The algorithm-based weighted voting and neural network classifiers show good classification performance for the diabetes and treatment groups. Although neural network performs better than weighted voting with higher classification rate, the interpretation of weighted voting is more straightforward. The study indicates that the choice of the gene selection procedure is at least as important as the choice of the classification procedure. We conclude that both mixed model-based and algorithm-based approaches provide the statistical evidence of the biological hypotheses that vanadyl sulfate treatment of diabetic animals restores gene expression patterns to normal. Although model-based and algorithm-based methods provide different strengths and perspective for the analysis of the same set of data, in general both can be considered and developed for analyzing factorial design experiments with multiple groups and factors. This study represents a major step towards the discovery of responsible genes related to diabetes and its treatment.
Liang
Yulan
Y
Department of Biostatistics, The State University of New York, Buffalo 14214, USA. yliang@buffalo.edu
Kelemen
Arpad
A
Tayo
Bamidele
B
D000465:Algorithms; D000818:Animals; D003920:Diabetes Mellitus / Q000628:therapy*; D019317:Evidence-Based Medicine / Q000706:statistics & numerical data*; D015870:Gene Expression / Q000187:drug effects*; D046228:Microarray Analysis; D051381:Rats; D014481:United States; D017968:Vanadium Compounds / Q000627:therapeutic use
D017968:Vanadium Compounds; C034028:vanadyl sulfate